Abstract: The present invention is directed to novel organometallic complexes as catalysts for the reaction of compounds with isocyanate and hydroxyl functional groups to form urethane and/or polyurethane and the process employing such catalysts. More particularly, the present invention is directed to novel complexes of zinc(II) with substituted amidines. These novel catalysts are useful for the production of urethanes and polyurethanes which are important in many industrial applications.

Abstract: The present invention relates to coating material compositions comprising at least one polyhydroxyl group-containing compound (A), at least one polyisocyanate group-containing compound (B) having free and/or blocked isocyanate groups, and at least one catalyst (D) based on a zinc-amidine complex which is prepared by reaction of 1.0 moles of at least one zinc(II) biscarboxylate with less than 2.0 moles of at least one amidine where R5=hydrogen and R1, R2, R3, and R4 are each identical or different radicals, R1 and R3 being hydrogen or an alkyl radical or an aryl radical, and R2 and R4 being an alkyl radical or an aryl radical.

Abstract: New hexa-coordinate iron (II) complexes comprising compounds of formula (I) are described. These compounds comprise a tetradentate ligand with donor atoms comprising nitrogen and phosphorus. These complexes are shown for the first time to be useful catalysts for the hydrogenation of ketones, aldehydes, or imines to produce alcohols or amines, and the asymmetric hydrogenation of prochiral ketones or imines to produce non-racemic alcohols or amines. The source of the hydrogen can be hydrogen gas or a hydrogen-donating molecule such as isopropanol or hydrogen-donating mixture such as formic acid and an amine depending on the structure of the catalyst. In certain embodiments, the axial ligands on the catalyst comprise organonitrile ligands, carbonyl ligands, isonitrile ligands, or combinations thereof. The catalysts and the preparation thereof are disclosed. A reaction using phosphine and diamine precursors that is templated by the iron ion is the preferred route to the catalysts.

Abstract: Provided is a germanium complex represented by Chemical Formula 1 wherein Y1 and Y2 are independently selected from R3, NR4R5 or OR6, and R1 through R6 independently represent (Ci-C7) alkyl. The provided germanium complex with an amidine derivative ligand is thermally stable, is highly volatile, and does not include halogen components. Therefore, it may be usefully used as a precursor to produce high-quality germanium thin film or germanium-containing compound thin film by metal organic chemical vapor deposition (MOCVD) or atomic layer deposition (ALD).

Abstract: A metal coordination complex of a biologically active moiety and a metal is disclosed. The complex confers to the biologically active moiety an improved performance which can include potency, stability, absorbability, targeted delivery, and combinations thereof.

Abstract: Disclosed are nickel allyl amidinate precursors having the formula: wherein each of R1, R2, R3, R4, R5, R6, R7, and R8 are independently selected from H; a C1-C4 linear, branched, or cyclic alkyl group, a C1-C4 linear, branched, or cyclic alkylsilyl group (mono, bis, or tris alkyl); a C1-C4 linear, branched, or cyclic alkylamino group; or a C1-C4 linear, branched, or cyclic fluoroalkyl group. Also disclosed are methods of synthesizing and using the disclosed precursors to deposit nickel-containing films on one or more substrates via a vapor deposition process.

Abstract: The present invention provides bimetallic complexes having increased activity in the copolymerization of carbon dioxide and epoxides. Also provided are methods of using such metal complexes in the synthesis of polymers. According to one aspect, the present invention provides metal complexes comprising an activating species with co-catalytic activity tethered to a multidentate ligand that is coordinated to one or more active metal centers of the complex.

Abstract: The present invention provides unimolecular metal complexes having increased activity in the copolymerization of carbon dioxide and epoxides. Also provided are methods of using such metal complexes in the synthesis of polymers. According to one aspect, the present invention provides metal complexes comprising an activating species with co-catalytic activity tethered to a multidentate ligand that is coordinated to the active metal center of the complex.

Abstract: The invention relates to a new catalyst component for the polymerization of olefins comprising a compound of formula CyLMZp, wherein M is a Group 4-6 metal, Z is an anionic ligand, p is the number of anionic ligands, Cy is a mono- or poly-substituted cyclopentadienyl-type ligand and L is a guanidinate ligand of the formula wherein: each A is independently selected from nitrogen or phosphorus and R, R1, R2 and R3 are independently selected from the group consisting of hydrogen, hydrocarbyl, silyl and germyl residues, substituted or not with one or more halogen, amido, phosphido, alkoxy, or aryloxy radicals. The invention also relates to a catalyst system for the polymerization of olefins and a process for the polymerization of at least one olefin having 2 to 20 carbon atoms.

Abstract: Provided are an organometallic precursor, wherein a carboxyhydrazide compound is coordinated to a central metal, and a metal film or pattern using the precursor. By using the organometallic precursor, highly pure metal films or patterns can be obtained through a simple low-temperature process.

Abstract: The present invention relates to a silver/polydiguanide complex and derivatives thereof including silver and polydiguanide having at least two biguanide moieties, wherein the silver is stabilized in an oxidation state of an integer of 0 to 4, a mole ratio between the silver and the polydiguanide is 1: 1-4, an average particle diameter of the complex is micrometer or nanometer, and zeta potential of the complex is greater than or equal to zero, a preparation method thereof, and an antibacterial composition for burns or wounds treatment including the same as an active ingredient.

Abstract: Methods for forming heteroleptic amidinate or guanidinate cyclopentadienyl containing transition metal precursors through synthesis reactions.

Abstract: This invention relates to complexes of certain divalent and polyvalent d-orbital metals of first transition series of the Periodic Table of Elements, from Group IV to Group VI, and including molybdenum, having a hydroxy acid [HA] and an amino acid [AA] moiety concurrently bound to a single said metal and having a spirocyclic, bidentate chelate structure of formula (I). Upon topical application said metal complexes undergo enhanced skin penetration without causing skin irritation.

Abstract: The present invention is directed to novel organometallic complexes as catalysts for the reaction of compounds with isocyanate and hydroxyl functional groups to form urethane and/or polyurethane and the process employing such catalysts. More particularly, the present invention is directed to novel complexes of zinc(II) with substituted amidines. These novel catalysts are useful for the production of urethanes and polyurethanes which are important in many industrial applications.

Abstract: A method for preparing a precursor of radioactive 3-iodobenzylguanidine- N,N?-bis(tert-butyloxycarbonyl)-3-(tri-n-butyltin)benzylguanidine) (MSnBG) is revealed. The method includes following steps. Firstly, obtain 3-iodobenzylguanidine bicarbonate by an addition reaction between 3-iodobenzylamine hydrochloride and cyanamide. Use di-tert-butyl dicarbonate as a protecting agent for NH group and convert 3-iodobenzylguanidine bicarbonate into N,N?-bis(tert-butyloxycarbonyl)-N-(3-iodobenzyl) guanidine. At last, under catalysis of bis(triphenylphosphine) palladium dichloride, obtain a final product MSnBG by a substitution reaction between N,N?-bis(tert-butyloxycarbonyl)-N-(3-iodobenzyl) guanidine and bis(tri-n-butyltin). MSnBG is used in no-carrier-added synthesis of [*l]MIBG.

Abstract: The present invention is compositions and methods for improving seed germination rates or speed using a composition comprising at least one high valency silver ion. The compositions and methods of the present invention are effective in treating biofilms.

Abstract: Provided is a germanium complex represented by Chemical Formula 1 wherein Y1 and Y2 are independently selected from R3, NR4R5 or OR6, and R1 through R6 independently represent (Ci-C7) alkyl. The provided germanium complex with an amidine derivative ligand is thermally stable, is highly volatile, and does not include halogen components. Therefore, it may be usefully used as a precursor to produce high-quality germanium thin film or germanium-containing compound thin film by metal organic chemical vapor deposition (MOCVD) or atomic layer deposition (ALD).

Abstract: This invention relates to processes for the production of organometallic compounds represented by the formula M(L)3 wherein M is a Group VIII metal, e.g., ruthenium, and L is the same or different and represents a substituted or unsubstituted amidinato group or a substituted or unsubstituted amidinato-like group, which process comprises (i) reacting a substituted or unsubstituted metal source compound, e.g., ruthenium (II) compound, with a substituted or unsubstituted amidinate or amidinate-like compound in the presence of a solvent and under reaction conditions sufficient to produce a reaction mixture comprising said organometallic compound, e.g., ruthenium (III) compound, and (ii) separating said organometallic compound from said reaction mixture. The organometallic compounds are useful in semiconductor applications as chemical vapor or atomic layer deposition precursors for film depositions.

Abstract: Provided are an organometallic precursor, wherein a carboxyhydrazide compound is coordinated to a central metal, and a metal film or pattern using the precursor. By using the organometallic precursor, highly pure metal films or patterns can be obtained through a simple low-temperature process.

Abstract: Cobalt precursors for forming metallic cobalt thin films in the manufacture of semiconductor devices, and methods of depositing the cobalt precursors on substrates, e.g., using chemical vapor deposition or atomic layer deposition processes. Packaged cobalt precursor compositions, and microelectronic device manufacturing systems are also described.

Abstract: A compound comprising a metal species and a biologically acceptable ligand, wherein the biologically acceptable ligand comprises a biguanide moiety, and wherein the biologically acceptable ligand forms a complex with the metal species in which the metal species is stabilised in an oxidation state greater than 1+. Compositions and medical devices comprising the compound. A method for the treatment or prophylaxis of microbial, including bacterial, infections, comprising the use of such compounds, compositions or medical devices.

Abstract: A compound of formula (I) wherein X is aluminium, gallium or indium; each Y, which may be the same or different, is nitrogen or phosphorus; R1 and R2, which may be the same or different, are hydrogen, halogen or alkyl; and R3 to R7, which may be the same or different, are hydrogen or a saturated group, or R3 and R4, or R5 and R6 together represent a saturated divalent link thus completing a ring.

Abstract: Polyethylene is formed by contacting ethylene with a novel iron or cobalt complex of a selected 1,4,7-triaza-3-oxa-1,4,6-heptatriene or 2,5,8-triaza-1,8-nonadiene, optionally in the presence of a cocatalyst such as an alkylaluminum compound. The polymers formed as useful for molding and in films.

Abstract: Polyethylene is formed by contacting ethylene with a novel iron or cobalt complex of a selected 1,4,7-triaza-3-oxa-1,4,6-heptatriene or 2,5,8-triaza-1,8-nonadiene, optionally in the presence of a cocatalyst such as an alkylaluminum compound. The polymers formed as useful for molding and in films.

Abstract: Hydroxy salts of formula:[M(OH).sub.(2-a) ].sup.a+ X.sup.b-.sub.a/b.zH.sub.2 Owhere M is zinc, copper or a mixture of the two and X denotes anions at least some of which display ultraviolet absorption over at least a portion of the wavelength range from 290 to 400 nanometers, their use as sunscreen agents and sunscreen compositions comprising them together with a cosmetically acceptable vehicle.

Abstract: Antimony oxo-metalate complexes having anti-viral activity are disclosed. The disclosed complexes are organic derivatives of tungstoantimonate or molybdoantimonate.

Abstract: Recovery of precious metals such as gold and silver from aqueous cyanide solutions thereof, by contact with a reagent containing a guanidine functionality. The guanidine reagent extracts the precious metal from the aqueous solution which is subsequentily stripped from the guanidine reagent and recovered by conventional methods. Certain novel guanidine compounds suitable for extracting gold and silver are disclosed.

Abstract: Disclosed are complexes of bismuth or antimony halides with amines having formula:R.cndot.(MeX.sub.3)y,where R is dicyandiamide, guanamine, 2-guanidinobenz-imidazole, isophoronediamine, piperazine, melamine or a compound having from 2 to 9 triazine rings condensed or linked to each other through at least one --NH-- group; Me is Bi or Sb; X is chlorine or bromine; and y is a number from 0.3 to 4. Processes for preparing the complexes and flame retardant thermoplastic polymer compositions containing the complexes are also disclosed.

Abstract: A method of making 1:1 complex salts of alpha amino acids and a metal ion which is either zinc or manganese, the method comprising reacting a water soluble zinc salt or manganese salt with an alpha amino acid in the presence of catalytically effective amount of ferric ion which aids in solubilizing the metal salt while simultaneously enhancing the formation of 1:1 complexes between the selected zinc or manganese salt and the desired alpha amino acid, particularly methionine.

Abstract: The compounds are the class of substituted hydrazine carboximidamides which are useful for inducing the regression and/or palliation of leukemia and related cancers in mammals when administered in amounts of from about one mg. to about 1.2 gm. per square meter of body surface area per day.